Logo

Transgenomic Shares Moving to Nasdaq

May 06, 2014 | staff reporter

NEW YORK (GenomeWeb) – Transgenomic today said that its common shares have been approved for uplisting to the Nasdaq Capital Market.

Its shares, which are currently listed on the OTC Bulletin Board under ticker symbol "TBIO," will start trading on the Nasdaq on May 9 under the same ticker symbol.

"We believe that trading on the Nasdaq market will expand our visibility and provide us access to a broader investor base, helping us translate our strategic growth initiatives and renewed focus on implementation into increased shareholder value going forward," Transgenomic President and CEO Paul Kinnon said in a statement.

The company filed with Nasdaq in January to have its shares listed on the exchange.

Filed under

PCR
Diagnostics
Nasdaq
Ice Cold-PCR
Precipio
Breaking News
The Scan

Gene Linked to Alkaline Sensitivity in Plants Identified

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.